SNCE

Science 37 (SNCE)

Science 37 Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNCE

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/13	04 : 55	GlobeNewswire Inc.	CORRECTION-- Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial	NASDAQ:SNCE	Science 37 Holdings Inc
2024/06/12	21 : 00	GlobeNewswire Inc.	Science 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical Trial	NASDAQ:SNCE	Science 37 Holdings Inc
2024/05/13	21 : 00	GlobeNewswire Inc.	Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance	NASDAQ:SNCE	Science 37 Holdings Inc
2024/05/09	23 : 00	GlobeNewswire Inc.	Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”	NASDAQ:SNCE	Science 37 Holdings Inc
2024/05/02	21 : 00	GlobeNewswire Inc.	Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial	NASDAQ:SNCE	Science 37 Holdings Inc
2024/04/17	21 : 00	GlobeNewswire Inc.	Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment	NASDAQ:SNCE	Science 37 Holdings Inc
2024/03/12	19 : 45	PR Newswire (US)	eMed completes tender offer for all outstanding shares of Science 37	NASDAQ:SNCE	Science 37 Holdings Inc
2024/03/04	20 : 18	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SNCE	Science 37 Holdings Inc
2024/03/04	20 : 01	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/20	13 : 16	PR Newswire (US)	Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/12	23 : 03	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/12	22 : 16	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/12	21 : 45	PR Newswire (US)	eMed commences tender offer for Science 37	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/09	21 : 49	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:SNCE	Science 37 Holdings Inc
2024/02/09	21 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2024/01/31	00 : 11	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:SNCE	Science 37 Holdings Inc
2024/01/30	06 : 10	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:SNCE	Science 37 Holdings Inc
2024/01/29	21 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2023/12/23	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2023/12/12	22 : 00	GlobeNewswire Inc.	Science 37 Receives Top Honors in Everest PEAK Matrix®	NASDAQ:SNCE	Science 37 Holdings Inc
2023/12/08	06 : 59	GlobeNewswire Inc.	Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:SNCE	Science 37 Holdings Inc
2023/12/05	21 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2023/12/05	21 : 00	GlobeNewswire Inc.	Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	NASDAQ:SNCE	Science 37 Holdings Inc
2023/11/30	06 : 13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2023/11/11	06 : 39	GlobeNewswire Inc.	Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:SNCE	Science 37 Holdings Inc
2023/11/07	20 : 39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SNCE	Science 37 Holdings Inc
2023/11/07	20 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNCE	Science 37 Holdings Inc
2023/11/07	20 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
2023/10/28	05 : 11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNCE	Science 37 Holdings Inc
2023/10/11	05 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SNCE	Science 37 Holdings Inc